Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment is a research paper published in Kidney International (2020). On theSindex it has a DataRank of 0. It has been cited 283 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Steno Diabetes Center Copenhagen (SDCC)
Grant: SDCC 3.A Complications
MeSH Terms
Keywords
Additional file 1 of Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
Additional file 1 of Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
Additional file 1 of Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
Additional file 1 of Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
Additional file 1 of Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism
Additional file 1 of Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism
Additional file 1 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 1 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 2 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 2 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 3 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 3 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 4 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 4 of Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data
Additional file 1 of Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
Additional file 1 of Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
Additional file 1 of Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus
Additional file 1 of Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus
Additional file 1 of Autonomic neuropathic symptoms in patients with diabetes: practical tools for screening in daily routine
Additional file 1 of Autonomic neuropathic symptoms in patients with diabetes: practical tools for screening in daily routine